BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34932399)

  • 21. Delta-tocotrienol augments cisplatin-induced suppression of non-small cell lung cancer cells via inhibition of the Notch-1 pathway.
    Ji X; Wang Z; Sarkar FH; Gupta SV
    Anticancer Res; 2012 Jul; 32(7):2647-55. PubMed ID: 22753722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Giganteaside D induces ROS-mediated apoptosis in human hepatocellular carcinoma cells through the MAPK pathway.
    Liu J; Wei X; Wu Y; Wang Y; Qiu Y; Shi J; Zhou H; Lu Z; Shao M; Yu L; Tong L
    Cell Oncol (Dordr); 2016 Aug; 39(4):333-42. PubMed ID: 27016209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergy with interferon-lambda 3 and sorafenib suppresses hepatocellular carcinoma proliferation.
    Yan Y; Wang L; He J; Liu P; Lv X; Zhang Y; Xu X; Zhang L; Zhang Y
    Biomed Pharmacother; 2017 Apr; 88():395-402. PubMed ID: 28122304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pentoxifylline induces apoptosis of HepG2 cells by reducing reactive oxygen species production and activating the MAPK signaling.
    Wang Y; Dong L; Li J; Luo M; Shang B
    Life Sci; 2017 Aug; 183():60-68. PubMed ID: 28583366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pristimerin synergistically sensitizes conditionally reprogrammed patient derived-primary hepatocellular carcinoma cells to sorafenib through endoplasmic reticulum stress and ROS generation by modulating Akt/FoxO1/p27
    Tang Y; Chen J; Li J; Zheng Y; Zhong X; Huang S; Chen B; Peng B; Zou X; Chen X
    Phytomedicine; 2021 Jun; 86():153563. PubMed ID: 33951569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erianin suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK MAPK signaling pathways.
    Yang L; Hu Y; Zhou G; Chen Q; Song Z
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32677672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eucalrobusone C suppresses cell proliferation and induces ROS-dependent mitochondrial apoptosis via the p38 MAPK pathway in hepatocellular carcinoma cells.
    Jian KL; Zhang C; Shang ZC; Yang L; Kong LY
    Phytomedicine; 2017 Feb; 25():71-82. PubMed ID: 28190473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of long non-coding RNA H19 on oxidative stress and chemotherapy resistance of CD133+ cancer stem cells via the MAPK/ERK signaling pathway in hepatocellular carcinoma.
    Ding K; Liao Y; Gong D; Zhao X; Ji W
    Biochem Biophys Res Commun; 2018 Jul; 502(2):194-201. PubMed ID: 29800569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression level of Bcl-XL critically affects sensitivity of hepatocellular carcinoma cells to LIGHT-enhanced and interferon-gamma-induced apoptosis.
    Li J; Shen F; Wu D; Wei LX; Wang YZ; Shi LH; Zou Y; Wu MC
    Oncol Rep; 2007 May; 17(5):1067-75. PubMed ID: 17390046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined anti-tumor effects of IFN-α and sorafenib on hepatocellular carcinoma in vitro and in vivo.
    Wang L; Jia D; Duan F; Sun Z; Liu X; Zhou L; Sun L; Ren S; Ruan Y; Gu J
    Biochem Biophys Res Commun; 2012 Jun; 422(4):687-92. PubMed ID: 22634008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-melanogenic effects of δ-tocotrienol are associated with tyrosinase-related proteins and MAPK signaling pathway in B16 melanoma cells.
    Ng LT; Lin LT; Chen CL; Chen HW; Wu SJ; Lin CC
    Phytomedicine; 2014 Jun; 21(7):978-83. PubMed ID: 24680613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lysophosphatidic acid enhances human hepatocellular carcinoma cell migration, invasion and adhesion through P38 MAPK pathway.
    Zhu B; Shi S; Ma YG; Fan F; Yao ZZ
    Hepatogastroenterology; 2012 May; 59(115):785-9. PubMed ID: 22020916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A paraptosis-like cell death induced by δ-tocotrienol in human colon carcinoma SW620 cells is associated with the suppression of the Wnt signaling pathway.
    Zhang JS; Li DM; He N; Liu YH; Wang CH; Jiang SQ; Chen BQ; Liu JR
    Toxicology; 2011 Jul; 285(1-2):8-17. PubMed ID: 21453743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C delta signaling.
    Hung JH; Lu YS; Wang YC; Ma YH; Wang DS; Kulp SK; Muthusamy N; Byrd JC; Cheng AL; Chen CS
    Cancer Res; 2008 Feb; 68(4):1204-12. PubMed ID: 18281497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. δ-Tocotrienol, Isolated from Rice Bran, Exerts an Anti-Inflammatory Effect via MAPKs and PPARs Signaling Pathways in Lipopolysaccharide-Stimulated Macrophages.
    Shen J; Yang T; Xu Y; Luo Y; Zhong X; Shi L; Hu T; Guo T; Nie Y; Luo F; Lin Q
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30287730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic cytotoxic effects of combined δ-tocotrienol and jerantinine B on human brain and colon cancers.
    Abubakar IB; Lim KH; Kam TS; Loh HS
    J Ethnopharmacol; 2016 May; 184():107-18. PubMed ID: 26947901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pegylated interferon-α inhibits the proliferation of hepatocellular carcinoma cells by downregulating miR-155.
    Zhang Y; Li X; Zhang Y; Wang L; Xu J; Du J; Guan Y
    Ann Hepatol; 2019; 18(3):494-500. PubMed ID: 31036495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dihydropyrimidine dehydrogenase predicts survival and response to interferon-α in hepatocellular carcinoma.
    Zhu WP; Liu ZY; Zhao YM; He XG; Pan Q; Zhang N; Zhou JM; Wang LR; Wang M; Zhan DH; Ma DN; Wang L
    Cell Death Dis; 2018 Jan; 9(2):69. PubMed ID: 29358721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. III-10, a newly synthesized flavonoid, induces cell apoptosis with the involvement of reactive oxygen species-mitochondria pathway in human hepatocellular carcinoma cells.
    Dai Q; Yin Q; Zhao Y; Guo R; Li Z; Ma S; Lu N
    Eur J Pharmacol; 2015 Oct; 764():353-362. PubMed ID: 26164795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gamma-tocotrienol promotes TRAIL-induced apoptosis through reactive oxygen species/extracellular signal-regulated kinase/p53-mediated upregulation of death receptors.
    Kannappan R; Ravindran J; Prasad S; Sung B; Yadav VR; Reuter S; Chaturvedi MM; Aggarwal BB
    Mol Cancer Ther; 2010 Aug; 9(8):2196-207. PubMed ID: 20682650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.